Lisa Danzig M.D.

Lisa Danzig, MD has a diverse work experience in various roles and companies. Lisa is currently working as an Advisor at Pandefense Advisory since June 2020. Prior to that, they were a Co-founder and Managing Partner at Amicitiam Partners starting from October 2018. Lisa also served as an Advisory Committee member at The Lemelson Foundation since October 2010. Lisa Danzig has worked as an Independent Director at OrSense since August 2014 and as a Director at Harmony Health since January 2019. Lisa held the position of Chief Medical Officer at Excision BioTherapeutics from July 2021 to September 2022. Additionally, Lisa Danzig has worked as Chief Medical Officer at PaxVax, Inc. from October 2017 to October 2018 and as Vice President, Clinical Development and Medical Affairs from June 2015 to September 2017. Lisa also served as an Advisor at The Batchery from May 2015 to January 2018 and at HealthExpense from the start of the company in 2010 to December 2015. Lisa Danzig's previous role was as the Global Head of Medical and Scientific Affairs at Grifols (formerly Novartis Diagnostics) from January 2014 to February 2015.

Lisa Danzig, MD obtained their Bachelor's degree in Biology from Reed College, where they studied from 1981 to 1985. Following that, they pursued Medicine and completed their MD degree at Health and Science jobs from 1986 to 1990. Prior to their undergraduate studies, Lisa attended Phillips Exeter Academy, although specific details regarding the duration and field of study are not available.